N,N-Dimethyltryptamine
In clinical developmentAlso known as 2-(3-indolyl)ethyldimethylamine, 3-(2-dimethylaminoethyl)indole, DMT, Dimethyltryptamine+2 more
2-(3-indolyl)ethyldimethylamine, 3-(2-dimethylaminoethyl)indole, DMT, Dimethyltryptamine, N,N-dimethyl-1H-indole-3-ethylamine, N,-N-dimethyltryptamine.
Recent clinical, regulatory, research and industry developments relating to this drug.
Neural Effects of Continuous Intravenous Infusion of N,N-dimethyltryptamine (DMT)
Investigation of Psychedelic Effects in Psychoactive Substances
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.
Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Journal of psychopharmacology (Oxford, England)2
- Current neuropharmacology1
- JAMA psychiatry1
- Proceedings of the National Academy of Sciences of the United States of America1
- Psychopharmacology1
- The American journal of psychiatry1
- Carhart-Harris RL2
- Nutt DJ2
- Ramaekers JG2
- Rosas FE2
- Timmermann C2
- Alamia A1
- Antonio JH1
- Arnfred S1
- Centre for Complexity Science2
- Centre for Psychedelic Research2
- Maastricht University2
- University of California2
- University of Sussex2
- Center for Eudaimonia and Human Flourishing1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as N,N-Dimethyltryptamine in the shared literature.
Studied across 2 of the same disease areas as N,N-Dimethyltryptamine in the shared literature.
Frequently co-studied with N,N-Dimethyltryptamine in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials